Waddill William D. 4
4 · Protagonist Therapeutics, Inc · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Waddill William D.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-10$12.88/sh+8,000$103,040→ 20,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-10−8,000→ 0 totalExercise: $12.88Exp: 2026-09-13→ Common Stock (8,000 underlying) - Sale
Common Stock
2024-09-10$45.00/sh−8,000$360,000→ 12,000 total
Footnotes (2)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.
- [F2]These stock options are fully vested.